Targeting Protein–Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches

A Monti, L Vitagliano, A Caporale, M Ruvo… - International journal of …, 2023 - mdpi.com
Protein–protein interfaces play fundamental roles in the molecular mechanisms underlying
pathophysiological pathways and are important targets for the design of compounds of …

Involvement of kallikrein-related peptidases in nervous system disorders

C Mella, CD Figueroa, C Otth… - Frontiers in Cellular …, 2020 - frontiersin.org
Kallikrein-related peptidases (KLKs) are a family of serine proteases that when dysregulated
may contribute to neuroinflammation and neurodegeneration. In the present review article …

A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma

F Xu, H Lin, P He, L He, J Chen, L Lin, Y Chen - Oncoimmunology, 2020 - Taylor & Francis
The tumor-suppressor gene tumor protein p53 (TP53) is one of the most commonly mutated
genes in human lung cancer, and TP53 mutations are associated with a worsened …

Spatial gene expression analysis reveals characteristic gene expression patterns of de novo neuroendocrine prostate cancer coexisting with androgen receptor …

R Watanabe, N Miura, M Kurata, R Kitazawa… - International Journal of …, 2023 - mdpi.com
Neuroendocrine prostate carcinoma (NEPC) accounts for less than 1% of prostate
neoplasms and has extremely poorer prognosis than the typical androgen receptor pathway …

Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer

D Loessner, P Goettig, S Preis, J Felber… - Expert Opinion on …, 2018 - Taylor & Francis
Introduction: Aberrant levels of kallikrein-related peptidases (KLK1-15) have been linked to
cancer cell proliferation, invasion and metastasis. In ovarian cancer, the KLK proteolytic …

Immunogenomic analyses of the prognostic predictive model for patients with renal cancer

T Feng, J Zhao, D Wei, P Guo, X Yang, Q Li… - Frontiers in …, 2021 - frontiersin.org
Background Renal cell carcinoma (RCC) is associated with poor prognostic outcomes. The
current stratifying system does not predict prognostic outcomes and therapeutic benefits …

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease

K Patra, A Soosaipillai, SB Sando, C Lauridsen… - Alzheimer's Research & …, 2018 - Springer
Abstract Background Kallikrein 6 (KLK6) is known to be an age-related protease expressed
at high levels in the central nervous system. It was previously shown to be involved in …

Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey

R Boumali, L Urli, M Naim, F Soualmia, K Kinugawa… - Biochimie, 2024 - Elsevier
Alzheimer's disease (AD) and related dementias constitute an important global health
challenge. Detailed understanding of the multiple molecular mechanisms underlying their …

Unveiling the Genomic Landscape of Intraductal Carcinoma of the Prostate Using Spatial Gene Expression Analysis

R Watanabe, N Miura, M Kurata, R Kitazawa… - International Journal of …, 2024 - mdpi.com
Intraductal carcinoma of the prostate (IDCP) has recently attracted increasing interest owing
to its unfavorable prognoses. To effectively identify the IDCP-specific gene expression …

Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells

A Divac Rankov, S Jovanović Stojanov… - Histochemistry and Cell …, 2023 - Springer
Identification of the signature molecular profiles involved in therapy resistance is of vital
importance in developing new strategies for treatments and disease monitoring. Protein …